HomeBusinessPraxis Precision Medicines reports Phase 2/3 study results for vormatrigine in epilepsy Praxis Precision Medicines reports Phase 2/3 study results for vormatrigine in epilepsy June 1, 2026byadmin Praxis Precision Medicines reports Phase 2/3 study results for vormatrigine in epilepsy Source link
SoftBank gains as report says it revives $10 billion OpenAI-backed loan talks SoftBank gains as report says it revives $10 billion OpenAI-backed loan talks Source link
Farmers & Merchants Bancorp earnings beat by $0.19, revenue topped estimates Farmers & Merchants Bancorp earnings beat by $0.19, revenue topped estimates Source link
Japan stocks lower at close of trade; Nikkei 225 down 2.04% Japan stocks lower at close of trade; Nikkei 225 down 2.04% Source link
